• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Cardiology

Elevated troponin T levels associated with increased mortality in patients presenting with dyspnea

byMichael WongandAlex Chan
April 12, 2023
in Cardiology, Emergency, Pulmonology
Reading Time: 2 mins read
Share on FacebookShare on Twitter

1. This retrospective study found that in patients presenting to the emergency department with acute dyspnea, elevated high-sensitivity cardiac troponin T (hs-cTnT) was associated with a higher 3-month all-cause mortality than those without an elevated hs-cTnT level.

2. Patients presenting with acute dyspnea along with an elevated hs-cTnT were older, more frequently male, more often hospitalized, had more deranged vital signs at admittance, were admitted with more severe symptoms, had fewer normal ECGs, and had a higher proportion of ECGs with ST-depression than patients without an elevated hs-cTnT.

Evidence Rating Level: 2 (Good)

Acute dyspnea is a common and challenging presentation in the emergency department, and a quick and safe identification of patients at risk for worse prognosis is important. High-sensitivity cardiac troponin T (hs-cTnT) has been found to safely rule out myocardial infarction (MI), though elevated levels can also mirror myocardial injury in other types of diseases other than MI. This retrospective study aimed to examine the association between myocardial injury and mortality in the absence of acute myocardial infarction, specifically noting the association between myocardial injury and patient characteristics. Data were obtained from the Acute Dyspnea Study (ADYS) cohort which was collected from December 2013 to January 2019. In total, 1001 adult patients presenting with acute dyspnea were included in the final analysis and these patients were interviewed by a research nurse using a standard questionnaire. Patients were also subdivided by levels of hs-cTnT and categorized into three groups based on their hs-cTnT level, no elevation (hs-cTnT < 15 ng/L), mild elevation (hs-cTnT 15 – 100 ng/L), and moderate elevation (hs-cTnT >100 ng/L). Compared to patients with normal hs-cTnT, patients with an elevated hs-cTnT were older, more frequently male, more often hospitalized, had more deranged vital signs at admittance, were admitted with more severe symptoms, had fewer normal ECGs, and had a higher proportion of ECGs with ST-depression. In addition, patients with increased hs-cTnT levels had a significantly higher proportion of comorbidities and higher mortality after 3-month follow-up. Regarding sex, men were found to have higher hs-cTnT levels than women (p<.003). When comparing the two groups with an increase in hs-cTnT above the clinical cut-off, the moderate increase group had a significantly higher hospitalization rate, a higher proportion of ‘high medical urgency cases’, a higher proportion of patients with renal disease, and higher 3 months mortality compared with the mild increase group. Furthermore, cox regression analysis for 3-month mortality in the three groups revealed five that were found to be significantly associated with mortality: respiratory frequency, saturation, CHF, renal disease, and BMI. Overall, a higher hs-cTnT level was associated with significantly higher 3-month mortality, and those with higher hs-cTnT levels tended to have more comorbidities and presented with more severe characteristics. A limitation of this study is the lack of previous interventions for cardiac disease, including medication, that could affect the results of this study. This study is important to further explore strategies and risk factors for negative outcomes in patients who present with acute dyspnea in the emergency department.

Click to read the study in BMC Emergency Medicine

Image: PD

RELATED REPORTS

Chronic exposure to particulate matter is associated with increased cardiovascular risk

The mortality in-hospital for patients undergoing elective catheter ablation for atrial fibrillation is low

A medical care at home program following hospitalization with acute decompensated heart failure may offer a safe and effective alternative to continued hospitalization

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cardiologyemergency medicinerespirologytroponin
Previous Post

Monthly prophylactic garadacimab significantly reduces hereditary angioedema attacks

Next Post

Wellness Check: Nutrition

RelatedReports

Cardiology

Chronic exposure to particulate matter is associated with increased cardiovascular risk

September 10, 2026
Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source
Cardiology

The mortality in-hospital for patients undergoing elective catheter ablation for atrial fibrillation is low

September 4, 2026
Remote patient monitoring did not reduce heart failure readmissions: The BEAT-HF trial
Cardiology

A medical care at home program following hospitalization with acute decompensated heart failure may offer a safe and effective alternative to continued hospitalization

July 24, 2026
Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source
Cardiology

Catheter ablation within 1 year of atrial fibrillation diagnosis is associated with reduced risk of recurrence

July 24, 2026
Next Post
Improved glycemic control in type 1 diabetics on very low-carbohydrate diets

Wellness Check: Nutrition

Variation in NICU antibiotic use not linked to outcomes

Doxycycline postexposure prophylaxis reduces the incidence of bacterial sexually transmitted infections

General anesthesia exposure in infants not linked to impaired cognitive development

Bariatric surgery associated with improved cardiovascular outcomes in patients with obesity and non-alcohol-related fatty liver disease

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Higher maternal body mass index is associated with increased risk of cardiovascular disease in offspring
  • Transanastomotic tubes not linked to anastomotic stricture after esophageal atresia repair
  • Artificial intelligence (AI) chatbot reduced depression, anxiety, and eating disorder risk symptoms
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.